| Old Articles: <Older 7821-7830 Newer> |
|---|
 |
The Motley Fool
August 24, 2011
Alexander Crawford |
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful How big could this market be?   |
The Motley Fool
August 23, 2011
Cindy Johnson |
5 Life Sciences Stocks Insiders Are Buying Folks in the know think these stocks will rise. Should you join them? |
The Motley Fool
August 23, 2011
Cindy Johnson |
8 Health-Care Provider Stocks Insiders Are Buying Folks in the know think these stocks will rise: MEDNAX... ExamWorks... Brookdale Senior Living... Tenet Healthcare... Aetna... National HealthCare... PSS World Medical... Health Management Associates... |
The Motley Fool
August 23, 2011
Cindy Johnson |
13 Health-Care Equipment Stocks Insiders Are Buying Folks in the know think these stocks will rise. Should you join them? |
The Motley Fool
August 22, 2011
Brian Orelli |
Speedy in Seattle Seattle Genetics gets an early approval of Adcentris. |
The Motley Fool
August 20, 2011
Rex Moore |
2 Positive Signs for Cubist Pharmaceuticals Cubist Pharmaceuticals appears to be in good shape in terms of the intangible assets ratio and tangible book value. |
The Motley Fool
August 20, 2011
Luke Timmerman |
Seattle Genetics Wins FDA Approval of First Drug FDA gives a quick turnaround on the new treatment for lymphomas. |
The Motley Fool
August 19, 2011
Alexander Crawford |
DNA Sequencing: The Next High-Growth Market in Biotech? We compiled a list of companies with a hand in the DNA sequencing market. Should you add these companies to your watch list? |
The Motley Fool
August 18, 2011
Todd Wenning |
What Does Medtronic Do With Its Free Cash? Is it a good steward of shareholder capital? |
The Motley Fool
August 18, 2011
Brian Orelli |
Running the Correct Trial Isn't Enough MELA Sciences' stock is up on claim that their trial meets FDA guidance, but they still need to prove that the device actually works. |
| <Older 7821-7830 Newer> Return to current articles. |
